These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20116331)

  • 1. Complement in neuroprotection and neurodegeneration.
    Yanamadala V; Friedlander RM
    Trends Mol Med; 2010 Feb; 16(2):69-76. PubMed ID: 20116331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The good, the bad, and the opportunities of the complement system in neurodegenerative disease.
    Schartz ND; Tenner AJ
    J Neuroinflammation; 2020 Nov; 17(1):354. PubMed ID: 33239010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement dysregulation in the central nervous system during development and disease.
    Lee JD; Coulthard LG; Woodruff TM
    Semin Immunol; 2019 Oct; 45():101340. PubMed ID: 31708347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement in neurodegeneration and neuroinflammation.
    Bonifati DM; Kishore U
    Mol Immunol; 2007 Feb; 44(5):999-1010. PubMed ID: 16698083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linkage between immunomodulation, neuroprotection and neurogenesis.
    Aharoni R; Arnon R
    Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegeneration.
    Hu Z; Li Y; Fang M; Wai MS; Yew DT
    Curr Med Chem; 2009; 16(11):1418-25. PubMed ID: 19355896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is complement good, bad, or both? New functions of the complement factors associated with inflammation mechanisms in the central nervous system.
    Tahtouh M; Croq F; Lefebvre C; Pestel J
    Eur Cytokine Netw; 2009 Sep; 20(3):95-100. PubMed ID: 19825517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation in the injured central nervous system: another dual-edged sword?
    Brennan FH; Anderson AJ; Taylor SM; Woodruff TM; Ruitenberg MJ
    J Neuroinflammation; 2012 Jun; 9():137. PubMed ID: 22721265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting complement in neurodegeneration: challenges, risks, and strategies.
    Zelek WM; Morgan BP
    Trends Pharmacol Sci; 2022 Aug; 43(8):615-628. PubMed ID: 35272861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The double-edged flower: roles of complement protein C1q in neurodegenerative diseases.
    Tenner AJ; Fonseca MI
    Adv Exp Med Biol; 2006; 586():153-76. PubMed ID: 16893071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylethanolamide in CNS health and disease.
    Mattace Raso G; Russo R; Calignano A; Meli R
    Pharmacol Res; 2014 Aug; 86():32-41. PubMed ID: 24844438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
    Brennan FH; Lee JD; Ruitenberg MJ; Woodruff TM
    Semin Immunol; 2016 Jun; 28(3):292-308. PubMed ID: 27049459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system-targeted complement inhibition mediates neuroprotection after closed head injury in transgenic mice.
    Rancan M; Morganti-Kossmann MC; Barnum SR; Saft S; Schmidt OI; Ertel W; Stahel PF
    J Cereb Blood Flow Metab; 2003 Sep; 23(9):1070-4. PubMed ID: 12973023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
    Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
    Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection.
    van Beek J; Elward K; Gasque P
    Ann N Y Acad Sci; 2003 May; 992():56-71. PubMed ID: 12794047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement in the brain.
    Veerhuis R; Nielsen HM; Tenner AJ
    Mol Immunol; 2011 Aug; 48(14):1592-603. PubMed ID: 21546088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of honokiol: from chemistry to medicine.
    Talarek S; Listos J; Barreca D; Tellone E; Sureda A; Nabavi SF; Braidy N; Nabavi SM
    Biofactors; 2017 Nov; 43(6):760-769. PubMed ID: 28817221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.
    Gasque P; Neal JW; Singhrao SK; McGreal EP; Dean YD; Van BJ; Morgan BP
    Mol Neurobiol; 2002 Feb; 25(1):1-17. PubMed ID: 11890454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement and blood-brain barrier integrity.
    Jacob A; Alexander JJ
    Mol Immunol; 2014 Oct; 61(2):149-52. PubMed ID: 25041699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.